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Abstract. For the development of medical and pharmaceutical chemistry is essential to 
optimize and change relevant structures, possessing biological activity. Herein we report the synthesis 
of some novel 1H-benzimidazolon-2-one derivatives using aza-Michael addition. 
Keywords: benzimidazole-2-one, aza-Michael addition. 
The benzimidazol-2-one plays essential role in the medicinal chemistry as building block of 
many biological active compounds as Droperidol, Domeperidone, Pimozid and HY-10355, that are 
used in clinical practice. Droperidrol is with general properties similar to those of Haloperidol and is 
used in conjunction with an opioid analgesic such as Fentanyl. Pimozid represents an antipsychotic 
drug and D2 dopamine receptor antagonist th binds with high affinity to the cloned 5-HT7 receptor. 
HY-10355 is a cell-permeable quinoxaline compound that has been shown to potently, selectively, 
allosterically, and reversibly inhibit Akt1, Akt2, and Akt3 activity (IC50 = 58 nM, 210 nM, and 2.12 
μM respectively). 
A series of novel benzimidazolones and their analogues, characterized by the presence of one or 
more methyl groups or other bioisosteric moieties at different positions of the phenyl ring at N-1 (1), were 
synthesized and evaluated as inhibitors of human immunodeficiency virus type-1 (HIV-1) [1]. 
Many of these compounds and especially 1,3-dihydro-2H-benzimidazole-2-one ring system 
have served as a basis for the design and synthesis of new compounds, possessing broad spectrum of 
biological activity as: potent NK1 antagonists [1], CGRP receptor antagonists [2], farnesyl transferase 
inhibitors [3], p38 inhibitors [4], cathepsin S inhibitors [5], 5-HT4 agonists and antagonists [6], 
progesterone receptor antagonist [7], respiratory syncytial virus (RSU) inhibitors [8]. 
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The development of efficient and practical methods for construction of this important 
heterocycle remains as an active area of synthetic research. The Michael addition reaction is a versatile 
synthetic methodology for the efficient coupling of electron poor olefins with a vast array of 
nucleophiles [9]. The nitrogen-donor version of the Michael addition is often referred to as the aza-
Michael reaction. Since amines can act as both nucleophiles and bases, no additional base is typically 
needed in these reactions. Here we report an approach for the use of the reaction of Michael for 
creating new benzimidazol-2-one derivatives [10]. 
The synthesis of the target compounds was performed as it is outlined in Fig.2, 3. 
The starting benzimidazol-2-ones were synthesized in one step synthesis by heating the 
mixture of appropriated 4-sunstituted-1,2-diaminobenzenes with urea at 130-140 oС for one hour. The 
melt was treated with water solution of sodium hydroxide, the solid obtained was filtered and the 
filtering was neutralized to afford the target benzimidazol-2-one. 
Fig. 2. Synthesis of 1H-benzimidazol-2-ones 
It is well known that the H-atoms linked to N-atoms of imidazole heterocycle possess 
prototropic properties, moreover there is an equilibrium between the hydroxy-form and the oxo-form 
of benzimidazol-2-one. In polar medium exists predominantly the oxo-form. Therefore the aza-
Michael addition of benzimidazolones to α,β-unsaturated carbonyl compounds was performed in DMF 
medium in molar ratio 1:2.5 under reflux. The reaction was monitored by use of TLC. The reaction 
was completed for 4-5 hours and after cooling the reaction mixture was poured in water, whereat the 
target compound crystallized. 
Fig. 3. Synthesis of 1,3-dihydro-substituted-1H-benzimidazol-2-ones 
The reactions were monitored by thin layer chromatography. The structures of all products 
were confirmed by melting points (m.p.), FT-IR - and 
1
H NMR spectroscopy. 
In conclusion, we have developed one pot synthetic method using aza-Mickael addition for the 
generation of novel 2,3-dihydro-1,3-disubstituted-1H-benzimidazol-2-one derivatives, which can serve 
as precursors for the preparing other new benzimidazole compounds.  
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